Transplantation of refreezed ovarian tissue after unexpected occurrence of endometriosis

AK Dietl, Ralf Dittrich, Inge Hoffmann, D Denschlag, A Hanjalic-Beck, A. Müller, M.W. Beckmann, Laura Lotz
In: Geburtshilfe und Frauenheilkunde · 2022 · vol. 82(10) , pp. e61 · doi:10.1055/s-0042-1756787 · W4307894760
OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This paper reports on the unexpected diagnosis of endometriosis during the transplantation of cryopreserved ovarian tissue, necessitating refreezing of the tissue.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text ⓘ

The paper describes ovarian-cryopreservation and later transplantation after unexpected endometriosis occurring in tissue planned for grafting. A 19-year-old woman with Hodgkin lymphoma cryopreserved ovarian tissue prior to chemotherapy; 14 years later laparoscopy intended to transplant the thawed tissue found endometriosis, leading to cancellation of the initial transplant, refreezing after lesion removal, and subsequent thawing and transplantation four months later. Ovarian function resumed two months post-transplant, mild stimulation supported follicle development, one oocyte was retrieved and fertilized via IVF, and a pregnancy with delivery of a healthy child occurred, with the authors concluding that refreezing was not a hindrance. The paper does not explicitly discuss adenomyosis; it is directly related to endometriosis because it reports a fertility preservation case where ovarian-tissue transplantation was modified due to diagnosed endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background Ovarian insufficiency is a concern for long-term cancer survivors. Ovarian-cryopreservation is a fertility preservation-technique through transplantation of frozen-thawed tissue; actual organ function and hormonal production is preserved. Perimenopausal endometriosis is rare, however it can be surprising diagnosed in transplantation of cryopreserved tissue. The thawed tissue may not be transplanted and has to be refrozen.
Full text 2,194 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Background

Ovarian insufficiency is a concern for long-term cancer survivors. Ovarian-cryopreservation is a fertility preservation-technique through transplantation of frozen-thawed tissue; actual organ function and hormonal production is preserved. Perimenopausal endometriosis is rare, however it can be surprising diagnosed in transplantation of cryopreserved tissue. The thawed tissue may not be transplanted and has to be refrozen.

Methods

19-year-old woman with Hodgkin lymphoma underwent ovarian-cryopreservation before chemotherapy. She had an irregular menses with perimenopausal hormonal laboratory after chemotherapy, but no endometriosis symptoms. Fourteen years later she request tissue transplantation due to the desire to have children and underwent laparoscopy with the intention of transplanting the thawed tissue. However, endometriosis was diagnosed, surgery was canceled and the tissue was refrozen. After removing the lesions the twice-cryopreserved tissue was thawed and transplanted four months later.

Results

Ovarian function returned two months after transplantation. Ten months later mild FSH-stimulation was initiated. When ultrasonography revealed a 17 mm follicle in the graft, one oocyte was obtained by follicular-puncture, fertilized by IVF and transferred. On day 14 after transfer, a positive hCG-Level was detected. After an uncomplicated pregnancy a healthy child was delivered.

Conclusions

We report the first pregnancy and live birth achieved using transplantation of thawed and refrozen ovarian tissue in a woman treated by chemotherapy and subsequent endometriosis surgery. Refreezing of cryopreserved ovarian tissue is not a hindrance to successful transplantation. Against the background of increasing numbers of candidates for transplantation of ovarian tissue is expected that the combination chemotherapy followed by endometriosis will increase. Publication History Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-10-08T06:33:43.470499+00:00
License: CC0 · commercial use OK